You are here: Home > Prescription(RX) Drugs > B > Biferarx (Alaven Pharmaceutical Llc)|
heme iron polypeptide,
iron dextran and
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Iron Supplement Tablets
BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.
Each BiferaRx™ tablet contains:
INDICATIONS AND USAGE
BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.
Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION
One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.
BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).
KEEP OUT OF REACH OF CHILDREN.
U.S. Patent No. 7,585,527
For medical inquiries call toll free 1-888-317-0001
PRINCIPAL DISPLAY PANEL - 90 Tablet Label
Revised: 03/2010 Alaven Pharmaceutical LLC
Reproduced with permission of U.S. National Library of Medicine
Copyright © 2017
|Over-the-counter (OTC) Drugs|